Although the Oomikron option can lead to a larger number of vaccinated, they will remain protected from severe disease, and the protection will be even more pronounced if people do the third vaccination. About this in an interview with The Wall Street Journal told Ugers Shahin, co-founder Biontech, who participated in the development of a coronavirus vaccine together with Pfizer.
Shahin noted that the Oomikron option is probably better than the “delta”, it is possible to avoid the action of antibodies generated by vaccines, but it is unlikely that the “Omicron” can bypass the immune response of the T-cells of the body for an infection, writes Israel ” Details “
On the eve of the Ministry of Health of Israel and South Africa published the effectiveness of the vaccine against the new strain of Coronavirus “Omicron”. Primary studies suggest that three doses of the vaccine effectively prevent infection and severe disease. Its efficiency is reduced by interest and amounts to 90 percent compared with 95 percent in relation to the “Delta”, resembles the publication.
Regarding the vaccine created by Moderna, its general director Stefan Bansiel said in an interview with British Financial Times that “the effectiveness of our vaccine against the new strain of Coronavirus” Oomikron “will be much lower than against other strains. I think it will be very Significant drop in efficiency. “